• Home
  • News
  • Portfolio News
  • TetraGenetics Appoints Alison Taunton-Rigby, Ellen Baron and Daniel Grau to its Board of Directors

TetraGenetics Appoints Alison Taunton-Rigby, Ellen Baron and Daniel Grau to its Board of Directors

03May

TetraGenetics Appoints Alison Taunton-Rigby, Ellen Baron and Daniel Grau to its Board of Directors

Portfolio News
TetraGenetics, a biopharmaceutical company developing novel antibody therapeutics for ion-channel mediated disorders, announced today the addition of three new board members: Alison Taunton-Rigby Ph.D., OBE, Ellen Baron Ph.D. and Daniel Grau M. Phil. Read more >>

Share this post

Related Posts

03Nov

How to Start a Celebrity-Backed Brand – The insider’s guide to who builds brands for stars like Jessica Alba and Seth Rogen, from top investors and incubators to talent agency pros.

Agencies are often the first stop for Hollywood brand builders. At UTA Ventures — which helped launch Issa Rae’s Sienna... read more
04Jan

Aircuity joins Real-Time Energy Management scheme in New York

Aircuity has announced that it has been named a New York State Energy Research and Development Authority (NYSERDA) Qualified Vendor... read more
08Jul

LaunchPad Medical Initiates its First European Clinical Study

LaunchPad Medical, Inc. announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United... read more
01Apr

Donors help Barrington boy gain sight

Jon Paul Corman tried on his new high-tech glasses Thursday and had just one word to say: "Wow!" In front of... read more
14Feb

Allevi Partners with Xylyx Bio to Create Liver Specific Bioinks

...Only a handful of researchers and companies around the world are tackling liver-specific bioinks, and one of them is now... read more
01Jun

Zylö Receives $294,000 NIH Phase I Grant to Advance its Cutaneous Lupus Program

Zylö Therapeutics Inc., developer of the Z-pod® topical delivery platform, has been awarded a two-year $294,000 Small Business Technology Transfer... read more
28Mar

Boston Harbor Angels Bet on New Frontier in Neuroscience

Boston Harbor Angels has invested in two neuroscience startups targeting stroke, TBI and Parkinson's Disease, leading a $1.3M angel seed... read more
30Nov

Blind Davenport man gets to see again for the first time in ten years

A Davenport man is now able to see the whole world again in a way he couldn't before. Ten years... read more
06Mar

Emovi is accelerating its growth through a 15M$ Series C investment led by TVM Capital Life Science

Emovi announced today its partnership with TVM Capital Life Science and co-investors StandUp Ventures and Desjardins Capital to support its... read more
07Jan

Ottobock Signs Distribution Agreement With Myomo

Ottobock, a market leader in technical orthopedics, and Myomo, Inc., a manufacturer of myoelectric orthotics, have reached an agreement for... read more